ArticleCell reports2026
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.
Andrew M Waters, Tala O Khatib, Bjoern Papke, Craig M Goodwin, G Aaron Hobbs, J Nathaniel Diehl, Runying Yang, A Cole Edwards, Katherine H Walsh, Rita Sulahian and 27 more
Abstract readPublished Erratum
In one paragraphArticle in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
37 authors.
Andrew M Waters
Tala O Khatib
Bjoern Papke
Craig M Goodwin
G Aaron Hobbs
J Nathaniel Diehl
Runying Yang
A Cole Edwards
Katherine H Walsh
Rita Sulahian
James M McFarland
Kevin S Kapner
Thomas S K Gilbert
Clint A Stalnecker
Sehrish Javaid
Anna Barkovskaya
Kajal R Grover
Priya S Hibshman
Devon R Blake
Antje Schaefer
Katherine M Nowak
Jennifer E Klomp
Tikvah K Hayes
Michelle Kassner
Nanyun Tang
Olga Tanaseichuk
Kaisheng Chen
Yingyao Zhou
Manpreet Kalkat
Laura E Herring
Lee M Graves
Linda Z Penn
Hongwei H Yin
Andrew J Aguirre
William C Hahn
Adrienne D Cox
Channing J Der
Funding
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5MTissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI SHIVDASANI, RAMESH A · 2007 to 2023
$33.2MIntegrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7MWashington University SPORE in Pancreatic CancerP50CA196510 · NCI · WASHINGTON UNIVERSITY · PI HAWKINS, WILLIAM G · 2016 to 2020
$10.9MProject 4: The role of codon bias in RAS tumorigenesisP01CA203657 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 2016 to 2020
$7.9MThe Dana-Farber Cancer Institute Cancer Target Discovery and Development CenterU01CA176058 · NCI · DANA-FARBER CANCER INST · PI HAHN, WILLIAM C. · 2013 to 2021
$7.8MTargeting undruggable RAS for cancer treatmentR35CA232113 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 2018 to 2024
$6.3MBIOLOGICAL ACTIVITY OF RAS ONCOGENESR01CA042978 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1986 to 2017
$5.9MCANCER CELL BIOLOGY TRAINING PROGRAMT32CA071341 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHANNING J. DER, Yuliya Pylayeva-Gupta · 1996 to 2026
$5.0MSystematic interrogation of the pancreatic cancer microenvironment in patient-derived specimensU01CA224146 · NCI · DANA-FARBER CANCER INST · PI HAHN, WILLIAM C. · 2017 to 2021
$3.0MIdentification of synthetic lethal interactors in pancreatic cancerU01CA199235 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COX, ADRIENNE D, DER, CHANNING J. · 2015 to 2019
$2.5MStromal Fibroblast Autophagy In Tumor Progression and DesmoplasiaR01CA213775 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEBNATH, JAYANTA · 2018 to 2022
$1.9MNCI NIH HHS F30 CA243253NCI NIH HHS F31 CA216965NCI NIH HHS F32 CA200313NCI NIH HHS F32 CA221005NCI NIH HHS F32 CA232529NCI NIH HHS F32 CA239328NCI NIH HHS K08 CA218420NCI NIH HHS P01 CA203657NCI NIH HHS P30 CA016086NCI NIH HHS P50 CA127003NCI NIH HHS P50 CA196510NCI NIH HHS R01 CA042978NCI NIH HHS R01 CA175747NCI NIH HHS R01 CA213775NCI NIH HHS R21 CA179193NCI NIH HHS R35 CA232113NCI NIH HHS T32 CA009156NCI NIH HHS T32 CA071341NCI NIH HHS U01 CA176058NCI NIH HHS U01 CA199235NCI NIH HHS U01 CA224146NIGMS NIH HHS T32 GM119999
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42308106
PMCPMC13536747
What OpenQuestion holds
Textmetadata
Read underepoch 390